Literature DB >> 24698190

Nordic databases to evaluate medications in pregnancy.

Helle Kieler.   

Abstract

The objective of this review is to describe the possibilities to assess drugs used in pregnancy by means of the Nordic health registers. The Nordic countries comprise five countries: Denmark, Finland, Iceland, Norway and Sweden and have a total population of 25 million. All five countries have in their national health registers for many years recorded information concerning all births, cancer diagnoses, hospital contacts, causes of death and dispensed drugs. The registers can be used for studying drugs dispensed during pregnancy and though most previous studies focused on risks of congenital abnormalities, other health consequences of maternal medication can also be assessed.
© 2014 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24698190     DOI: 10.2515/therapie/2014009

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  2 in total

1.  Maternal and infant characteristics: differences and similarities between the Nordic countries and the US.

Authors:  Lukas Löfling; Gabriella Bröms; Shahram Bahmanyar; Helle Kieler
Journal:  Clin Epidemiol       Date:  2016-08-03       Impact factor: 4.790

Review 2.  Administrative Claims Data Versus Augmented Pregnancy Data for the Study of Pharmaceutical Treatments in Pregnancy.

Authors:  Susan E Andrade; Anick Bérard; Hedvig M E Nordeng; Mollie E Wood; Marleen M H J van Gelder; Sengwee Toh
Journal:  Curr Epidemiol Rep       Date:  2017-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.